Novel antigens of CAR T cell therapy: New roads; old destination

por Safarzadeh Kozani, Pooria, Safarzadeh Kozani, Pouya, Rahbarizadeh, Fatemeh
Publicado 2021

CAR-T cell therapy in T-cell malignancies: Is success a low-hanging fruit?

por Safarzadeh Kozani, Pouya, Safarzadeh Kozani, Pooria, Rahbarizadeh, Fatemeh
Publicado 2021

Optimizing the Clinical Impact of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia: Looking Back While Moving Forward

por Safarzadeh Kozani, Pouya, Safarzadeh Kozani, Pooria, Rahbarizadeh, Fatemeh
Publicado 2021

Strategies for Dodging the Obstacles in CAR T Cell Therapy

por Safarzadeh Kozani, Pooria, Safarzadeh Kozani, Pouya, Rahbarizadeh, Fatemeh, Khoshtinat Nikkhoi, Shahryar
Publicado 2021

Strategies for having a more effective and less toxic CAR T-cell therapy for acute lymphoblastic leukemia

por Hashem Boroojerdi, Mohadese, Rahbarizadeh, Fatemeh, Safarzadeh Kozani, Pouya, Kamali, Elahe, Safarzadeh Kozani, Pooria
Publicado 2020

Recent Advances in Solid Tumor CAR-T Cell Therapy: Driving Tumor Cells From Hero to Zero?

por Safarzadeh Kozani, Pouya, Safarzadeh Kozani, Pooria, Ahmadi Najafabadi, Milad, Yousefi, Fatemeh, Mirarefin, Seyed Mohamad Javad, Rahbarizadeh, Fatemeh
Publicado 2022

Nanobody-based CAR-T cells for cancer immunotherapy

por Safarzadeh Kozani, Pouya, Naseri, Abdolhossein, Mirarefin, Seyed Mohamad Javad, Salem, Faeze, Nikbakht, Mojtaba, Evazi Bakhshi, Sahar, Safarzadeh Kozani, Pooria
Publicado 2022

CAR-T cell therapy in triple-negative breast cancer: Hunting the invisible devil

por Nasiri, Fatemeh, Kazemi, Mehrasa, Mirarefin, Seyed Mohamad Javad, Mahboubi Kancha, Maral, Ahmadi Najafabadi, Milad, Salem, Faeze, Dashti Shokoohi, Setareh, Evazi Bakhshi, Sahar, Safarzadeh Kozani, Pouya, Safarzadeh Kozani, Pooria
Publicado 2022